PMC:7441788 / 1281-1544
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T14 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T15 | 209-217 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T15 | 71-73 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T16 | 185-187 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T12 | 71-73 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T13 | 185-187 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T12 | 94-102 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T13 | 209-217 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 9-112 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 47 | 103-111 | Species | denotes | patients | Tax:9606 |
| 57 | 71-73 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 74-77 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 185-187 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 188-191 | Chemical | denotes | HCQ | MESH:D006886 |
| 71 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 209-217 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T12 | 94-102 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T13 | 209-217 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 36-57 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 47 | 103-111 | Species | denotes | patients | Tax:9606 |
| 57 | 71-73 | Chemical | denotes | CQ | MESH:D002738 |
| 58 | 74-77 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 185-187 | Chemical | denotes | CQ | MESH:D002738 |
| 60 | 188-191 | Chemical | denotes | HCQ | MESH:D006886 |
| 71 | 94-102 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 72 | 209-217 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T15 | 9-112 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 36-57 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |